Tasly Pharmaceutical Group Co Ltd Financial Flexibility Index
Tasly Pharmaceutical Group Co Ltd financial flexibility index. Tasly Pharmaceutical Group Co Ltd (600535) has a Financial Flexibility Index of 0.24x as of December 2025. Free cash flow of CN¥669.91 Million (operating CF CN¥552.13 Million minus capex CN¥117.78 Million) represents 0% of total liabilities (CN¥2.79 Billion). See 600535 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tasly Pharmaceutical Group Co Ltd (2001–2025)
Financial flexibility index of Tasly Pharmaceutical Group Co Ltd from 2001 to 2025. Historical Financial Flexibility Index trend for Tasly Pharmaceutical Group Co Ltd across 25 annual periods. Check 600535 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Tasly Pharmaceutical Group Co Ltd Financial Flexibility Index by Year (2001–2025)
Tasly Pharmaceutical Group Co Ltd financial flexibility index by year from 2001 to 2025. Year-by-year free cash flow to debt coverage for Tasly Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 600535 operating cash flow.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.65x | CN¥1.81 Billion | CN¥1.42 Billion | CN¥2.79 Billion | ▼ -28.2% |
| 2024 | 0.90x | CN¥2.58 Billion | CN¥2.01 Billion | CN¥2.87 Billion | ▲ +11.7% |
| 2023 | 0.81x | CN¥3.24 Billion | CN¥2.58 Billion | CN¥4.02 Billion | ▲ +13.9% |
| 2022 | 0.71x | CN¥2.69 Billion | CN¥2.29 Billion | CN¥3.80 Billion | ▼ -32.3% |
| 2021 | 1.04x | CN¥3.37 Billion | CN¥2.80 Billion | CN¥3.23 Billion | ▲ +95.2% |
| 2020 | 0.54x | CN¥2.20 Billion | CN¥1.79 Billion | CN¥4.11 Billion | ▲ +169.8% |
| 2019 | 0.20x | CN¥2.41 Billion | CN¥1.68 Billion | CN¥12.15 Billion | ▲ +21.9% |
| 2018 | 0.16x | CN¥2.27 Billion | CN¥1.49 Billion | CN¥13.96 Billion | ▲ +757.5% |
| 2017 | -0.02x | CN¥-310.99 Million | CN¥-822.56 Million | CN¥12.56 Billion | ▼ -113.2% |
| 2016 | 0.19x | CN¥1.68 Billion | CN¥1.15 Billion | CN¥8.92 Billion | ▲ +34.5% |
| 2015 | 0.14x | CN¥1.08 Billion | CN¥340.00 Million | CN¥7.71 Billion | ▼ -19.9% |
| 2014 | 0.17x | CN¥1.37 Billion | CN¥616.76 Million | CN¥7.85 Billion | ▲ +5.0% |
| 2013 | 0.17x | CN¥1.01 Billion | CN¥346.17 Million | CN¥6.07 Billion | ▼ -32.1% |
| 2012 | 0.24x | CN¥803.33 Million | CN¥413.31 Million | CN¥3.28 Billion | ▲ +25.5% |
| 2011 | 0.20x | CN¥557.71 Million | CN¥135.14 Million | CN¥2.86 Billion | ▼ -29.5% |
| 2010 | 0.28x | CN¥561.18 Million | CN¥395.05 Million | CN¥2.03 Billion | ▼ -0.8% |
| 2009 | 0.28x | CN¥517.19 Million | CN¥400.39 Million | CN¥1.85 Billion | ▲ +0.9% |
| 2008 | 0.28x | CN¥374.72 Million | CN¥260.21 Million | CN¥1.36 Billion | ▼ -26.8% |
| 2007 | 0.38x | CN¥422.78 Million | CN¥221.55 Million | CN¥1.12 Billion | ▲ +46.8% |
| 2006 | 0.26x | CN¥395.97 Million | CN¥140.56 Million | CN¥1.54 Billion | ▼ -40.2% |
| 2005 | 0.43x | CN¥511.22 Million | CN¥214.90 Million | CN¥1.19 Billion | ▼ -38.0% |
| 2004 | 0.69x | CN¥572.88 Million | CN¥203.27 Million | CN¥826.42 Million | ▲ +2.9% |
| 2003 | 0.67x | CN¥387.74 Million | CN¥59.00 Million | CN¥575.74 Million | ▼ -48.6% |
| 2002 | 1.31x | CN¥332.31 Million | CN¥206.22 Million | CN¥253.70 Million | ▲ +124.5% |
| 2001 | 0.58x | CN¥203.12 Million | CN¥83.77 Million | CN¥348.19 Million | — |